Light therapy and sonidegib for multiple BCC
Part of Cancer clinical trials.
This trial tests a combination of blue-light therapy (a type of photodynamic therapy) and an oral medication called sonidegib for people with multiple basal cell carcinomas (BCCs). It may be an option if you have several BCCs that are not suitable for surgery or radiation, or if you prefer not to have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have at least 3 BCCs (nodular type) that are between 0.5 cm and 5 cm in size on your head, neck, trunk, arms, or legs
- Your BCC diagnosis is confirmed by a doctor, with 1 to 3 lesions biopsied at least 2 weeks before treatment
- Surgery or radiation may not be practical or desirable for you
- You are not allergic to porphyrins or have certain skin sensitivity conditions
- You can swallow capsules and are willing to follow study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (SP-002) combined with vismodegib for people with locally advanced basal cell carcinoma, a type of skin cancer that can't be treated with surgery or has come back after surgery. The goal is to see if this combination is safe and effective.
This trial tests a new gel and light treatment for actinic keratosis (rough, sun-damaged spots) on the arm. It aims to see if it can safely remove these spots and prevent new ones.
This trial tests a new treatment that combines light (photodynamic therapy) and sound (sonodynamic therapy) to treat a common type of skin cancer called nodular basal cell carcinoma. The goal is to see if this combination works better than light alone for small tumors.
This trial tests if giving a combination of two immunotherapy drugs (nivolumab and relatlimab) before surgery works better than one drug alone for people with large or high-risk basal cell skin cancer that needs surgery. The goal is to shrink the cancer and make surgery easier.
This trial tests combining a skin cream (imiquimod), a laser treatment, and an immunotherapy drug (cemiplimab) before surgery for high-risk basal cell carcinoma. The goal is to see if this combination shrinks tumors enough to make surgery less disfiguring or damaging to nearby functions.
This study tests a light-activated treatment (photodynamic therapy) for a very early form of skin cancer on the face. It may offer an alternative to surgery.
Hear when a new Basal Cell Carcinoma (BCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.